Mozz,
As you alluded too the more time we get to spend in the FDA's face I think it can only help the PPS OA case. Whilst I think the PPS OA timelines are pretty set (ie we have to do the two studies etc) I do think this lifts our credability with the FDA and further derisking PAR's PPS push.
Hopefully the strategy pays off and does not end up being another cash drag .. with another future CR required.
DYOD
Poolboy
- Forums
- ASX - By Stock
- PAR
- New orphan drug designation
New orphan drug designation, page-15
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
28.5¢ |
Change
0.010(3.64%) |
Mkt cap ! $99.69M |
Open | High | Low | Value | Volume |
27.5¢ | 28.5¢ | 27.5¢ | $8.001K | 28.94K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 52536 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.5¢ | 15217 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 52536 | 0.275 |
8 | 150850 | 0.270 |
3 | 28850 | 0.265 |
5 | 396083 | 0.260 |
4 | 67850 | 0.255 |
Price($) | Vol. | No. |
---|---|---|
0.285 | 15217 | 5 |
0.290 | 28358 | 4 |
0.295 | 16148 | 2 |
0.300 | 35634 | 3 |
0.305 | 55400 | 4 |
Last trade - 10.50am 11/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online